Equities analysts expect Perrigo Company PLC (NYSE:PRGO) to report earnings of $0.98 per share for the current quarter, according to Zacks. Twelve analysts have made estimates for Perrigo’s earnings. The lowest EPS estimate is $0.83 and the highest is $1.05. Perrigo reported earnings of $1.28 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 23.4%. The firm is scheduled to announce its next quarterly earnings results on Thursday, March 7th.

On average, analysts expect that Perrigo will report full year earnings of $4.55 per share for the current year, with EPS estimates ranging from $4.40 to $4.62. For the next year, analysts expect that the business will post earnings of $4.61 per share, with EPS estimates ranging from $4.03 to $5.04. Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Perrigo.

A number of equities analysts have commented on PRGO shares. Wells Fargo & Co set a $46.00 target price on Perrigo and gave the company a “hold” rating in a report on Sunday, December 30th. Royal Bank of Canada set a $63.00 target price on Perrigo and gave the company a “hold” rating in a report on Friday, November 9th. Cantor Fitzgerald set a $107.00 target price on Perrigo and gave the company a “buy prgo” rating in a report on Thursday, December 20th. Morgan Stanley set a $67.00 target price on Perrigo and gave the company a “hold” rating in a report on Sunday, December 23rd. Finally, Leerink Swann cut their price target on Perrigo from $70.00 to $56.00 in a report on Monday, December 24th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $77.36.

Several large investors have recently bought and sold shares of PRGO. FMR LLC boosted its position in shares of Perrigo by 114.3% during the third quarter. FMR LLC now owns 11,080,094 shares of the company’s stock worth $784,471,000 after buying an additional 5,909,969 shares during the period. Iridian Asset Management LLC CT acquired a new stake in Perrigo in the third quarter valued at $136,248,000. Ceredex Value Advisors LLC raised its stake in Perrigo by 132.0% in the third quarter. Ceredex Value Advisors LLC now owns 2,828,159 shares of the company’s stock valued at $200,234,000 after buying an additional 1,609,009 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in Perrigo by 3,574.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,430,805 shares of the company’s stock valued at $37,000 after buying an additional 1,391,870 shares in the last quarter. Finally, First Eagle Investment Management LLC acquired a new stake in Perrigo in the third quarter valued at $47,818,000. 85.72% of the stock is owned by hedge funds and other institutional investors.

Shares of Perrigo stock traded up $1.13 during mid-day trading on Friday, reaching $48.13. 160,696 shares of the stock traded hands, compared to its average volume of 1,627,139. Perrigo has a fifty-two week low of $36.28 and a fifty-two week high of $90.72. The stock has a market capitalization of $6.47 billion, a P/E ratio of 9.76, a PEG ratio of 1.76 and a beta of 1.31. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.85 and a quick ratio of 1.26.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Recommended Story: What kind of dividend yield to CEF’s pay?

Get a free copy of the Zacks research report on Perrigo (PRGO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.